Cindy Tahl Net Worth & Insider Trades
Cindy Tahl - General Counsel and Secretary, Fate Therapeutics Inc
What is Cindy Tahl's Net Worth?
The current estimated net worth of Fate Therapeutics Inc's General Counsel and Secretary, Cindy Tahl, is estimated to be about $29.06M . Cindy Tahl owns about 177,598 units of Fate Therapeutics Inc common stock. In the last 8 years at Fate Therapeutics Inc, Cindy Tahl has sold an estimated value of $28.46M worth.
What is Cindy Tahl's Past Insider Trading?
Cindy Tahl's largest purchase order was 50,000 units , worth over $327.5K on January 4, 2022. Cindy Tahl's largest sale order was 55,534 units , worth over $4.73M on July 2, 2021. In total, Cindy Tahl has made about 28 transactions over 8 years of their time at Fate Therapeutics Inc. Cindy Tahl usually trades in January, with the busiest year in 2021. The most recent transaction was a sale order of 11,553 units , worth over $60.54K on January 11, 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cindy Tahl
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Cindy Tahl's Salary in 2020?
As General Counsel and Secretary of Fate Therapeutics Inc, Cindy Tahl has a total base salary of $390,000 . Cindy Tahl received compensation valued at about $2,459,097 in 2020 after becoming General Counsel and Secretary. The vast majority of their compensation came in the form of stock awards of $549,750 , option awards of $1,324,347 , other earnings, plans or compensations of $195,000 , and
What is Cindy Tahl's' Mailing Address?
- Mailing address is C/o Fate Therapeutics, Inc. 3535 General Atomics Court, Ste 200 San Diego CA 92121 CA
Fate Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| J. Scott Wolchko | 2020 | $570,000 | - | $1,451,340 | $3,222,577 | $356,250 | - | $5,600,167 |
| J. Scott Wolchko | 2019 | $540,000 | - | $4,137,500 | $5,732,955 | $310,500 | - | $10,720,955 |
| J. Scott Wolchko | 2018 | $516,000 | - | - | $2,756,998 | $258,000 | - | $3,530,998 |
| Edward J. Dulac III | 2020 | $142,500 | $137,917 | $1,420,800 | $3,786,529 | $75,833 | $120,000 | $5,683,579 |
| Bahram Valamehr, Ph.D. | 2020 | $390,000 | - | $549,750 | $1,324,347 | $195,000 | - | $2,459,097 |
| Bahram Valamehr, Ph.D. | 2019 | $375,000 | - | $744,750 | $1,547,898 | $150,938 | - | $2,818,586 |
| Bahram Valamehr, Ph.D. | 2018 | $321,865 | - | - | $2,138,235 | $117,250 | - | $2,577,350 |
| Cindy R. Tahl, J.D. | 2020 | $390,000 | - | $549,750 | $1,324,347 | $195,000 | - | $2,459,097 |
| Cindy R. Tahl, J.D. | 2019 | $375,000 | - | $744,750 | $1,547,898 | $150,938 | - | $2,818,586 |
| Cindy R. Tahl, J.D. | 2018 | $350,000 | - | - | $906,465 | $122,500 | - | $1,378,965 |
| Daniel D. Shoemaker, Ph.D. | 2020 | $390,000 | - | $549,750 | $1,324,347 | $195,000 | - | $2,459,097 |
| Daniel D. Shoemaker, Ph.D. | 2019 | $375,000 | - | $744,750 | $1,547,898 | $150,938 | - | $2,818,586 |
| Daniel D. Shoemaker, Ph.D. | 2018 | $365,000 | - | - | $842,338 | $127,750 | - | $1,335,088 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1434316/000119312521124699/d85377ddef14a.htm
What are Fate Therapeutics Inc's Past Insider Trades?
Fate Therapeutics Inc's most recent insider trade came on August 21, 2023 by Edward Dulac III who sold 4,718 units worth $13.21K . In the last 10 years, insiders at Fate Therapeutics Inc have sold an estimated value of $160.92M and bought an estimated value of $205.58M worth of shares. Insider trading is most common in January, with the busiest year in 2021. The most active traders at the company are Scott Wolchko, President and CEO, Cindy Tahl, General Counsel and Secretary, and Bahram Valamehr, Chief R&D Officer .
FATE THERAPEUTICS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||